Stay updated on Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.

Latest updates to the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, indicating a potential improvement or change in the content or functionality.SummaryDifference0.6%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.8%
- Check18 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
- Check25 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check33 days agoChange DetectedDifference0.6%
- Check40 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference1%
Stay in the know with updates to Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.